MedTrace Logo

NeuroGlove PTSD Study

NCT06050590 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-08-27

No results posted yet for this study

Summary

This is a prospective, home-based, interventional clinical study in which 6 subjects will be enrolled. Six (6) subjects who suffer from post-traumatic stress disorder will receive treatment using the NeuroGlove.

Conditions

  • PTSD
  • Post Traumatic Stress Disorder

Interventions

DEVICE

NeuroGlove

Study participant with PTSD will undergo daily at home treatment using the NeuroGlove.

Sponsors & Collaborators

  • NeuroGlove LLC

    lead INDUSTRY

Principal Investigators

  • Eric Nussbaum, MD · NeuroGlove LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-14
Primary Completion
2024-08-27
Completion
2024-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06050590 on ClinicalTrials.gov